Theriva Biologics, Inc. (TOVX)

CIK 894158 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Theriva Biologics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 24, 2026S-80001104659-26-100340
Aug 11, 20268-K0001104659-26-093782
Aug 11, 202610-Q0001104659-26-093786
Aug 6, 20268-K0001104659-26-091674
Aug 4, 20268-K0001104659-26-090064
Jul 7, 20268-K0001104659-26-080962
Jun 29, 2026DEF 14A0001104659-26-078859
Jun 29, 2026ARS0001104659-26-078961
Jun 18, 2026PRE 14A0001104659-26-075756
Jun 11, 20268-K0001104659-26-072633
Jun 5, 20268-K0001104659-26-070966
May 5, 20268-K0001104659-26-055679
May 5, 202610-Q0001104659-26-055689
Apr 30, 2026DEF 14A0001104659-26-052960
Apr 20, 2026PRE 14A0001104659-26-045553
Apr 17, 20268-K0001104659-26-044906
Apr 9, 20268-K0001104659-26-041507
Mar 23, 20268-K0001104659-26-033051
Mar 16, 2026DEF 14A0001104659-26-028593
Mar 12, 20268-K0001104659-26-026765
Mar 12, 202610-K0001104659-26-026767
Mar 4, 2026PRE 14A0001104659-26-023448
Feb 18, 20268-K0001104659-26-016792
Feb 12, 20268-K0001104659-26-013907
Jan 12, 20268-K0001104659-26-002750